These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1781465)

  • 1. Which bottom line?
    Shane R
    Am J Hosp Pharm; 1991 Oct; 48(10):2130. PubMed ID: 1781465
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketplace. How drug company mergers affect HMOs and hospitals.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 Jun; 51(23):suppl 2 p.. PubMed ID: 10167794
    [No Abstract]   [Full Text] [Related]  

  • 3. Shades of gray. Secondary drug distributors raise questions.
    Lee J
    Mod Healthc; 2011 Oct; 41(41):10, 12. PubMed ID: 22111494
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech drugs: high costs becoming hard to swallow.
    Wagner M
    Mod Healthc; 1992 Jan; 22(2):24-5, 28-9. PubMed ID: 10115803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotechnology drugs create new maze of concerns for hospitals.
    Lumsdon K
    Hospitals; 1991 Dec; 65(23):32, 34-5. PubMed ID: 1937456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products.
    Becker C
    Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appraisal of drug costs to hospitals.
    Salman L
    J Hosp Dent Pract; 1979; 13(1):5-9. PubMed ID: 296180
    [No Abstract]   [Full Text] [Related]  

  • 8. Hospitals hit with higher drug costs.
    Wagner M
    Mod Healthc; 1991 Mar; 21(10):16. PubMed ID: 10109612
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugmaker boycott may be expanded.
    Wagner M
    Mod Healthc; 1991 Oct; 21(43):9. PubMed ID: 10114646
    [No Abstract]   [Full Text] [Related]  

  • 10. Reform calls for new relationships.
    Black RC
    Healthc Exec; 1993; 8(3):25. PubMed ID: 10125603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. As hospital drug budgets soar, pharmacy's role is being rewritten.
    Lumsdon K
    Hospitals; 1992 May; 66(10):34, 36, 38-40. PubMed ID: 1577448
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital pharmacy and industry--conflict and collaboration.
    Gouveia WA
    Am J Hosp Pharm; 1984 Jul; 41(7):1391-4. PubMed ID: 6465157
    [No Abstract]   [Full Text] [Related]  

  • 13. The rising cost of pharmaceuticals: a hospital executive's perspective.
    Shorb GS
    Am J Hosp Pharm; 1993 Aug; 50(8 Suppl 4):S4-6. PubMed ID: 8213861
    [No Abstract]   [Full Text] [Related]  

  • 14. Leading 1994 dollar volume pharmaceuticals.
    Ramspacher S
    Hosp Pharm; 1995 Aug; 30(8):666-9, 673. PubMed ID: 10144644
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the process of medication budget forecasting.
    Vermeulen LC; Marnocha RM; Thielke TS
    Pharm Pract Manag Q; 1998 Apr; 18(1):72-80. PubMed ID: 10177544
    [No Abstract]   [Full Text] [Related]  

  • 16. Survey shows steady growth in hospitals' drug expenses.
    Scott L
    Mod Healthc; 1995 Jun; 25(25):80. PubMed ID: 10143114
    [No Abstract]   [Full Text] [Related]  

  • 17. The rising cost of pharmaceuticals: a director of pharmacy's perspective.
    Pierpaoli PG
    Am J Hosp Pharm; 1993 Aug; 50(8 Suppl 4):S6-8. PubMed ID: 8213862
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug Price Index declines as prices weaken for older drugs.
    Hosp Mater Manage; 1986 May; 11(5):21-2. PubMed ID: 10277138
    [No Abstract]   [Full Text] [Related]  

  • 19. Slowing rate of cost increases in the pharmacy.
    Roark M
    Hospitals; 1993 Jan; 67(2):56. PubMed ID: 8419282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replies to the question: should the practice of drug sampling be retained or eliminated?
    Hosp Formul; 1994 Oct; 29(10):720-2. PubMed ID: 10137849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.